Literature DB >> 21160685

Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Santhi Maniam1, Janio Szklaruk.   

Abstract

Magnetic resonance imaging (MRI) of the liver is slowly transitioning from a problem solving imaging modality to a first line imaging modality for many diseases of the liver. The well established advantages of MRI over other cross sectional imaging modalities may be the basis for this transition. Technological advancements in MRI that focus on producing high quality images and fast imaging, increasing diagnostic accuracy and developing newer function-specific contrast agents are essential in ensuring that MRI succeeds as a first line imaging modality. Newer imaging techniques, such as parallel imaging, are widely utilized to shorten scanning time. Diffusion weighted echo planar imaging, an adaptation from neuroimaging, is fast becoming a routine part of the MRI liver protocol to improve lesion detection and characterization of focal liver lesions. Contrast enhanced dynamic T1 weighted imaging is crucial in complete evaluation of diseases and the merit of this dynamic imaging relies heavily on the appropriate timing of the contrast injection. Newer techniques that include fluoro-triggered contrast enhanced MRI, an adaptation from 3D MRA imaging, are utilized to achieve good bolus timing that will allow for optimum scanning. For accurate interpretation of liver diseases, good understanding of the newer imaging techniques and familiarity with typical imaging features of liver diseases are essential. In this review, MR sequences for a time efficient liver MRI protocol utilizing newer imaging techniques are discussed and an overview of imaging features of selected common focal and diffuse liver diseases are presented.

Entities:  

Keywords:  Contrast agents; Liver; Magnetic resonance imaging; Oncology

Year:  2010        PMID: 21160685      PMCID: PMC2999331          DOI: 10.4329/wjr.v2.i8.309

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  56 in total

1.  Fast T2-weighted MR imaging: impact of variation in pulse sequence parameters on image quality and artifacts.

Authors:  Tao Li; Scott A Mirowitz
Journal:  Magn Reson Imaging       Date:  2003-09       Impact factor: 2.546

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

Review 3.  Cirrhosis: MR imaging features.

Authors:  Katsuyoshi Ito; Donald G Mitchell; Evan S Siegelman
Journal:  Magn Reson Imaging Clin N Am       Date:  2002-02       Impact factor: 2.266

4.  Cystic focal liver lesions in the adult: differential CT and MR imaging features.

Authors:  K J Mortelé; P R Ros
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

5.  Spectrum of MRI appearances of untreated metastases of the liver.

Authors:  Ioana-Maria Danet; Richard C Semelka; Polytimi Leonardou; Larissa Braga; Georgeta Vaidean; John T Woosley; Masayuki Kanematsu
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

Review 6.  Imaging of focal liver lesions.

Authors:  Hyun-Jung Jang; Hojun Yu; Tae Kyoung Kim
Journal:  Semin Roentgenol       Date:  2009-10       Impact factor: 0.800

7.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Authors:  Tejas Parikh; Stephen J Drew; Vivian S Lee; Samson Wong; Elizabeth M Hecht; James S Babb; Bachir Taouli
Journal:  Radiology       Date:  2008-01-25       Impact factor: 11.105

9.  Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.

Authors:  K J Mortelé; M Praet; H Van Vlierberghe; B de Hemptinne; K Zou; P R Ros
Journal:  Abdom Imaging       Date:  2002 Nov-Dec

Review 10.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

View more
  5 in total

1.  Pathological and MR-DWI study of the acute hepatic injury model after stem cell transplantation.

Authors:  Quan-Liang Shang; En-Hua Xiao; Qi-Chang Zhou; Jian-Guang Luo; Hai-Jun Wu
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 2.  In Vivo Tracking of Tissue Engineered Constructs.

Authors:  Carmen J Gil; Martin L Tomov; Andrea S Theus; Alexander Cetnar; Morteza Mahmoudi; Vahid Serpooshan
Journal:  Micromachines (Basel)       Date:  2019-07-16       Impact factor: 2.891

3.  Retrospective four-dimensional magnetic resonance imaging of liver: Method development.

Authors:  Henna Kavaluus; Tiina Seppälä; Lauri Koivula; Eero Salli; Juhani Collan; Kauko Saarilahti; Mikko Tenhunen
Journal:  J Appl Clin Med Phys       Date:  2020-12-03       Impact factor: 2.102

4.  Non-invasive diagnosis of abdomino-pelvic masses: role of multimodality imaging.

Authors:  Vijayanadh Ojili; Sree Harsha Tirumani; Kedar N Chintapalli; Gowthaman Gunabushanam
Journal:  J Clin Imaging Sci       Date:  2013-01-30

5.  Early detection and staging of chronic liver diseases with a protein MRI contrast agent.

Authors:  Mani Salarian; Ravi Chakra Turaga; Shenghui Xue; Maysam Nezafati; Khan Hekmatyar; Jingjuan Qiao; Yinwei Zhang; Shanshan Tan; Oluwatosin Y Ibhagui; Yan Hai; Jibiao Li; Rao Mukkavilli; Malvika Sharma; Pardeep Mittal; Xiaoyi Min; Shella Keilholz; Liqing Yu; Gengshen Qin; Alton Brad Farris; Zhi-Ren Liu; Jenny J Yang
Journal:  Nat Commun       Date:  2019-10-29       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.